Vasca's Vascular Access Device 510(k) Data Show Zero Infection Rate
This article was originally published in The Gray Sheet
Executive Summary
Infection rates using Vasca's LifeSite vascular access implant fell to zero after the firm's conversion to exclusive use of isopropyl alcohol as the pre-dialysis and post-dialysis antimicrobial sterilizing solution.
You may also be interested in...
Vasca Launches LifeSite Hemodialysis System Following 510(k) Clearance
LifeSite developer Vasca, Inc. launched the hemodialysis access system on Aug. 28, immediately following FDA clearance.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.